United States Endoscopic Stricture Management Device Market 2026 | Growth Drivers, Trends & Market Forecast, Competitive Landscape & Investment Opportunities

Market Size and Growth

The global Endoscopic stricture management device market is estimated to reach at a CAGR of 5.6% during the forecast period (2024-2031).

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/endoscopic-stricture-management-device-market?sb

Key Development:

United States: Recent Industry Developments

✅ In January 2026, EndoQuest Robotics received FDA approval to initiate the final stage of its PARADIGM clinical trial for a robotic‐assisted endoscopic system designed to improve precision in complex GI stricture navigation and treatment.

✅ In December 2025, Boston Scientific expanded use of the SpyGlassTM DS II direct visualization system during ERCP procedures for managing biliary and pancreatic strictures, enhancing diagnostic confidence and therapeutic guidance under endoscopy.

✅ In December 2025, Olympus continued to enhance its portfolio with flexible metal stents and advanced balloon dilation tools, including improved EZDilate endoscopic balloon dilators and a broad lineup of HANAROSTENT products for GI strictures.

✅ In December 2025, global attention on next‐generation biodegradable and drug‐eluting endoscopic stents gained traction as industry innovators highlighted improved flexibility, reduced migration and long‐term lumen patency in stricture therapy.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=endoscopic-stricture-management-device-market

Japan: Recent Industry Developments

✅ In January 2026, endoscopic closure and therapeutic systems demand rose in Japan as hospitals increasingly adopted advanced closure devices and clip systems to support stricture procedures across GI and urological applications.

✅ In December 2025, Japan's medical device regulatory landscape evolved under the updated Pharmaceutical and Medical Device Act (PMD Act), streamlining assessment pathways for innovative endoscopic solutions, including stricture management tools.

✅ In December 2025, broader market analysis underscored Japan's expanding endoscopy device ecosystem, driven by demographic trends and higher procedure volumes for GI therapeutic interventions that include stricture management devices.

✅ In December 2025, MICRO‐TECH Endoscopy showcased the DAT Closure Device at DIES 2026, highlighting precision tissue closure aimed at preventing post‐procedure strictures in GI endoscopy settings.

Key Players:

=> Becton, Dickinson and Company, Boston Scientific Corporation, Olympus Corporation, Cook Medical, CONMED Corporation, Merit Medical Systems, Hobbs Medical, Medi-Globe GmbH, Micro-Tech Endoscopy USA and Medorah Meditek Pvt Ltd.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/endoscopic-stricture-management-device-market?sb

Key Segments:

By Product Type

Stent dominates with an estimated 35% share, widely used in minimally invasive procedures for maintaining lumen patency in gastrointestinal, urological, and bronchial applications.

Covered Stents account for 15%, designed for preventing tissue ingrowth and improving patient outcomes in strictures and obstructions.

Uncovered Stents hold 10%, preferred for temporary or selective applications where tissue integration is beneficial.

Self-expanding Stents contribute 12%, offering flexibility and ease of deployment in tortuous anatomical regions.

Other Stents account for 8%, including specialized or custom stents for unique medical conditions.

Balloon Dilators dominate the dilator segment with 10% share, used in endoscopic and urological procedures to widen strictures.

Bougie Dilators hold 6%, primarily used in gastrointestinal procedures for gradual dilation of esophageal strictures.

Other Dilators account for 4%, including custom or specialized dilators for niche applications.

By Application

Gastrointestinal Endoscopy leads with 40% share, reflecting the growing prevalence of gastrointestinal disorders and minimally invasive interventions.

Laparoscopy holds 15%, used in a wide range of abdominal and pelvic surgeries.

Urology Endoscopy contributes 12%, supporting the treatment of urinary tract obstructions and related conditions.

Bronchoscopy accounts for 10%, facilitating pulmonary diagnostics and interventions.

Others make up 23%, including ENT, cardiology, and other niche endoscopic applications.

By End-User

Hospitals dominate with 55% share, driven by high patient throughput, surgical volumes, and adoption of advanced endoscopic tools.

Ambulatory Surgical Centres (ASCs) hold 30%, reflecting the growth of outpatient procedures and minimally invasive surgeries.

Others contribute 15%, including specialized clinics, research institutes, and diagnostic centers.

By Region

North America leads with 32% share, supported by high adoption of advanced endoscopic technologies and a well-established healthcare infrastructure.

Europe follows with 28%, driven by increasing minimally invasive procedures and government healthcare initiatives.

Asia Pacific accounts for 25%, reflecting rising healthcare investments, increasing surgical volumes, and improving medical infrastructure in emerging countries.

Latin America and Middle East & Africa together hold 15%, driven by growing awareness, healthcare infrastructure development, and demand for minimally invasive surgeries.

Outlook & Opportunity Analysis (2024-2031)

The global endoscopic stents and dilators market is expected to grow steadily, fueled by the rising prevalence of gastrointestinal, urological, and pulmonary disorders, increasing adoption of minimally invasive procedures, and technological advancements in stent design. Opportunities exist in self-expanding stents, covered stents, and next-generation dilators targeting precision, patient safety, and outpatient procedures.

FAQ

Q: What is the growth rate of the Endoscopic stricture management device Market?

A: The market is projected to expand at a compound annual growth rate (CAGR) of 5.6% during the forecast period from 2024 to 2031.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.